The "Subcutaneous" Shift: How 2026 is Moving Cancer Care...

agregó una foto Health

2026-02-12 05:27:14 -

The "Subcutaneous" Shift: How 2026 is Moving Cancer Care Out of the Infusion Chair.

By mid-2026, the industry has officially entered the era of "Patient-Centric Delivery." This year, the focus is on the transition of blockbuster monoclonal antibodies from Intravenous (IV) to Subcutaneous (SC) formulations. This innovation is a primary driver for the market, as it allows patients to receive life-saving treatments in under 10 minutes rather than spending several hours in a...

0 Commentarios 0 Acciones 33 Views 0 Vista previa